The Swiss Stock Exchange began Wednesday’s session without real momentum. While the results season continues, with in particular in Switzerland those of UBS, investors remained circumspect in the face of the announcement of a new three-month stay in the commercial negotiations between the United States and China, they preferred to wait for the decision of the federal reserve in the evening.
In addition to the wave of half-yearly performance of the day, including that of Microsoft in the evening, investors will also look into the evolution of the gross domestic product (GDP) in the second quarter in Europe and the United States. In France, economic growth reached 0.3% in the second quarter, driven by stocks and a slight rebound in household consumption.
On the side of Wall Street on Tuesday, the main clues closed slightly, yielding under a certain nervousness of investors pending the outcome of the meeting of the Monetary Policy Committee of the American Federal Reserve (Fed) on Wednesday. John Plassard, partner of the Cité Gestion Cité Management in charge of the investment strategy, also explains the withdrawal by profits.
In terms of commercial relations, the United States and China have agreed to extend their price pricing by 90 days, initially scheduled to expire on August 12, after discussions deemed “frank and in-depth” in Stockholm. This postponement for the moment avoids a brutal rise in customs duties at 145% on Chinese exports and maintains the current levels of 30% on Chinese products and 10% on American goods.
This respite offers a potentially more stable framework to prepare a possible meeting between Xi Jinping and Donald Trump by the end of the year, notes John Plassard.
On the Swiss Stock Exchange, the SMI, after having opened on an imperceptible withdrawal of 0.07%, was always hesitant during the first exchanges, the flagship index noting shortly before 9:15 am to 11,957.07 points, a compaction of just 0.02%. The SLI gave it 0.03% to 1991.43 points, while the enlarged SPI indicator took a very small 0.02% to 16,691.65 points.
Among the 31 constitutive values of the Swiss Leader Index, 16 lost ground and 14 won, while the Giant of the ABB electrical engineering was a Surlace.
The Lindt participation voucher (+0.9%) took the lead, in the fight with the world number one of certification and the SGS inspection (+0.9%also) and the fortune manager Julius Baer (+0.9%). UBS (+0.8%) was not far away. The number one Swiss banking has released between April and late June a net profit of $ 2.40 billion (1.93 billion francs), multiplied by two over one year. The establishment with the three keys notably saw its assets under management jump to 6618 billion, against 6153 billion in late March.
Of the three heavyweights on the side, the two pharmas, the good rock and the nominative Novartis rose 0.3%and 0.6%respectively, while the Nestlé diet (-0.02%) found itself below the balance.
The generic medication giant Sandoz took him 0.4%, after having signed a memorandum of understanding not binding with the German Evotec in order to acquire its internal capacities of development and manufacturing just-Evotec Biologics in Toulouse, in France.
On the extended market, Huber+Suhner took over more than 13%, the Appenzello-Zurichois specialist in electrical and optical connectivity systems that have expressed a large command.
Inficon tumbled 8.3%. The manufacturer of measuring instruments has disappointed expectations in terms of profitability and adjusting its annual prospects. Autoeum fell 6.2%, the automotive subcontractor having seen his sales and his profitability fell in the first half of 2025.
Bucher industries also plunged 6.1%. The manufacturer of agricultural machinery and road vehicles revised its forecasts for the financial year 2025. (Awp)
